MarketsnMarkets

This interactive model quantifies the volume sales potential of 18 products across 25 marques in 10 countries for the years 2006, 2007 and 2008. It also displays both IAM and OES potential.

After 4 years of steady growth, the migraine market across the seven major regions was valued at $4.6 billion in 2008.

The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market.

Datamonitor estimates 2009 allergic rhinitis sales of $5 billion in the seven major markets, and forecasts a decline to $4.2 billion by 2019.

The database includes market overview and distribution Channels Overview, per regions and leading markets.

In 2009, HIV antiretroviral sales across the seven major markets totalled $11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009.

Quantifies the size and segmentation of the light commercial vehicle market. In addition to providing an overview of the total LCV market, details the segmentation of the market by finance method.

Datamonitor expects Novartis's Gilenia (fingolimod) to launch at the end of 2010 as a first-line therapy, while Merck Serono's oral cladribine is anticipated to launch at the start of 2011.

The report presents actual information about the market of ventilated facades and its state in May 2010.

The marketing research contains actual information about the market of sealants and construction foam and its state in May 2010.